Commercialization Learnings with Novartis Gene Therapies' President Chris Fox
Cell & Gene: The Podcast
00:00
Introduction
Chris Box, president of Novartis Gene Therapies, talks about the company's efforts to improve newborn screening, reduce time to treatment, and enhance access to therapies for rare neurological genetic disorders, highlighting the collaboration between Novartis and Novartis Gene Therapies.
Transcript
Play full episode
